Correlation Between Ningbo MedicalSystem and Maccura Biotechnology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and Maccura Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and Maccura Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and Maccura Biotechnology Co, you can compare the effects of market volatilities on Ningbo MedicalSystem and Maccura Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of Maccura Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and Maccura Biotechnology.

Diversification Opportunities for Ningbo MedicalSystem and Maccura Biotechnology

0.96
  Correlation Coefficient

Almost no diversification

The 3 months correlation between Ningbo and Maccura is 0.96. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and Maccura Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Maccura Biotechnology and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with Maccura Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Maccura Biotechnology has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and Maccura Biotechnology go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and Maccura Biotechnology

Assuming the 90 days trading horizon Ningbo MedicalSystem Biotechnology is expected to generate 1.19 times more return on investment than Maccura Biotechnology. However, Ningbo MedicalSystem is 1.19 times more volatile than Maccura Biotechnology Co. It trades about 0.01 of its potential returns per unit of risk. Maccura Biotechnology Co is currently generating about -0.02 per unit of risk. If you would invest  1,116  in Ningbo MedicalSystem Biotechnology on September 21, 2024 and sell it today you would earn a total of  1.00  from holding Ningbo MedicalSystem Biotechnology or generate 0.09% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy100.0%
ValuesDaily Returns

Ningbo MedicalSystem Biotechno  vs.  Maccura Biotechnology Co

 Performance 
       Timeline  
Ningbo MedicalSystem 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.
Maccura Biotechnology 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Maccura Biotechnology Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Maccura Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.

Ningbo MedicalSystem and Maccura Biotechnology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ningbo MedicalSystem and Maccura Biotechnology

The main advantage of trading using opposite Ningbo MedicalSystem and Maccura Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, Maccura Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Maccura Biotechnology will offset losses from the drop in Maccura Biotechnology's long position.
The idea behind Ningbo MedicalSystem Biotechnology and Maccura Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stocks Directory
Find actively traded stocks across global markets